The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Focused Issues

심혈관질환과 SGLT2억제제: 박진주; J Korean Diabetes. 2024;25(1):26-34. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.26

만성콩팥병과 SGLT2억제제: 고은실, 정성진; J Korean Diabetes. 2024;25(1):16-25. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.16

당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제: 김지윤, 김신곤; J Korean Diabetes. 2024;25(1):9-15. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.9

Information Desks

최신 당뇨병 치료제의 특징: 윤누리; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Opinion

Sodium-Glucose Cotransporter 2 Inhibitor의 안전성: 임상에서 고려해야 할 점: Soo Lim; J Korean Diabetes. 2019;20(3):127-135. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.127

Focused Issues

Sodium-Glucose Cotransporter 2 억제제의 작용 기전 및 다양한 효과: Kyung Soo Kim; J Korean Diabetes. 2019;20(2):74-80. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.74
Cited By 1

Volume 25, No. 3

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

5,452	Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients
4,836	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
1,504	Technological Innovations Transforming Diabetes Care in Practice
1,410	Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
2,634	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2024 by Korean Diabetes Association. All rights reserved.